340B Advocacy Alliance Bulletin

Jan 17, 2023
AHA 340B Hospital Members Urged to Submit Comments on HRSA’s Proposed Rule on the 340B Administrative Dispute Resolution Process, Model Comment Letter Available
Jan 10, 2023
The U.S. District Court for the District of Columbia today decided to allow the Department of Health and Human Services to propose an appropriate remedy for its past underpayments to hospitals participating in the 340B Drug Pricing Program.
Dec 2, 2022
Digital ad campaign from AHA, others spotlights the importance and value of the 340B program The AHA, along with six other national hospital groups, is running a new digital ad campaign promoting to policymakers and influencers the benefits of the 340B program to patients and communities
Nov 14, 2022
The AHA today released a new report showing how the unlawful actions of drug companies to limit 340B pricing with community and specialty pharmacies are having an adverse impact on access to care for patients and communities across the country.
Nov 4, 2022
The AHA has issued a Special Bulletin with details on provisions of the Centers for Medicare & Medicaid Services’ outpatient prospective payment system final rule for calendar year 2023, which includes updates to policies for the 340B Drug Pricing Program.
Oct 11, 2022
It’s in everyone’s best interest to keep the 340B program strong, wrote AHA President and CEO Rick Pollack in the Congress Blog at The Hill, published Oct. 10.
Oct 4, 2022
After court ruling for AHA in 340B case, HHS says it will start adjusting payment rates for certain 340B hospitals within approximately two weeks
Sep 30, 2022
The United States District Court for the District of Columbia Sept 28 ruled in favor of the AHA, holding that the Department of Health and Human Services must immediately halt the departments’ unlawful cuts to outpatient reimbursement rates for the remainder of 2022 for certain hospitals that…